{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T19:46:47Z","timestamp":1782330407630,"version":"3.54.5"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004919","name":"King Abdulaziz City for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004919","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12944-016-0298-0","type":"journal-article","created":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T02:15:17Z","timestamp":1471400117000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cysteinyl leukotriene correlated with 8-isoprostane levels as predictive biomarkers for sensory dysfunction in autism"],"prefix":"10.1186","volume":"15","author":[{"given":"Hanan","family":"Qasem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Al-Ayadhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afaf","family":"El-Ansary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,17]]},"reference":[{"key":"298_CR1","first-page":"731935","volume":"2013","author":"BS Gadad","year":"2013","unstructured":"Gadad BS, et al. Neuropathology and animal models of autism: genetic and environmental factors. Autism Res Treat. 2013;2013:731935.","journal-title":"Autism Res Treat"},{"issue":"1","key":"298_CR2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pcl.2011.10.010","volume":"59","author":"WG Silver","year":"2012","unstructured":"Silver WG, Rapin I. Neurobiological basis of autism. Pediatr Clin N Am. 2012;59(1):45\u201361. x.","journal-title":"Pediatr Clin N Am"},{"issue":"1","key":"298_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00234-009-0583-y","volume":"52","author":"JS Verhoeven","year":"2010","unstructured":"Verhoeven JS, et al. Neuroimaging of autism. Neuroradiology. 2010;52(1):3\u201314.","journal-title":"Neuroradiology"},{"key":"298_CR4","unstructured":"Gordan J. One in Every 50 Children Has Autism. UCLA Medical School CDC; 2013"},{"issue":"1","key":"298_CR5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0883073807307102","volume":"23","author":"M Xue","year":"2008","unstructured":"Xue M, et al. Autism spectrum disorders: concurrent clinical disorders. J Child Neurol. 2008;23(1):6\u201313.","journal-title":"J Child Neurol"},{"key":"298_CR6","first-page":"354","volume":"2","author":"M Herbert","year":"2005","unstructured":"Herbert M. Autism: a brain disorder or a disorder that affects the brain. Clin Neuropsychiatry. 2005;2:354\u201379.","journal-title":"Clin Neuropsychiatry"},{"issue":"6","key":"298_CR7","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/02646830500381930","volume":"17","author":"CA Pardo","year":"2005","unstructured":"Pardo CA, Vargas DL, Zimmerman AW. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry. 2005;17(6):485\u201395.","journal-title":"Int Rev Psychiatry"},{"issue":"1\u20132","key":"298_CR8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2008.12.002","volume":"207","author":"X Li","year":"2009","unstructured":"Li X, et al. Elevated immune response in the brain of autistic patients. J Neuroimmunol. 2009;207(1\u20132):111\u20136.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"298_CR9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-1-14","volume":"1","author":"WJ Streit","year":"2004","unstructured":"Streit WJ, Mrak RE, Griffin WS. Microglia and neuroinflammation: a pathological perspective. Journal of neuroinflammation. 2004;1(1):14.","journal-title":"Journal of neuroinflammation"},{"key":"298_CR10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ntt.2012.07.006","volume":"36","author":"PE Goines","year":"2013","unstructured":"Goines PE, Ashwood P. Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. Neurotoxicol Teratol. 2013;36:67\u201381.","journal-title":"Neurotoxicol Teratol"},{"issue":"1","key":"298_CR11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","volume":"7","author":"B Uttara","year":"2009","unstructured":"Uttara B, et al. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009;7(1):65\u201374.","journal-title":"Curr Neuropharmacol"},{"key":"298_CR12","doi-asserted-by":"crossref","first-page":"467180","DOI":"10.1155\/2011\/467180","volume":"2011","author":"A Melo","year":"2011","unstructured":"Melo A, et al. Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives. Oxidative Med Cell Longev. 2011;2011:467180.","journal-title":"Oxidative Med Cell Longev"},{"issue":"3","key":"298_CR13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pathophys.2006.05.007","volume":"13","author":"A Chauhan","year":"2006","unstructured":"Chauhan A, Chauhan V. Oxidative stress in autism. Pathophysiology. 2006;13(3):171\u201381.","journal-title":"Pathophysiology"},{"issue":"21","key":"298_CR14","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.lfs.2004.04.038","volume":"75","author":"A Chauhan","year":"2004","unstructured":"Chauhan A, et al. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin--the antioxidant proteins. Life Sci. 2004;75(21):2539\u201349.","journal-title":"Life Sci"},{"issue":"5","key":"298_CR15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.plefa.2005.06.002","volume":"73","author":"X Ming","year":"2005","unstructured":"Ming X, et al. Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot Essent Fatty Acids. 2005;73(5):379\u201384.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"10\u201311","key":"298_CR16","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.clinbiochem.2009.03.011","volume":"42","author":"Y Al-Gadani","year":"2009","unstructured":"Al-Gadani Y, et al. Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children. Clin Biochem. 2009;42(10\u201311):1032\u201340.","journal-title":"Clin Biochem"},{"issue":"3","key":"298_CR17","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00406-004-0456-7","volume":"254","author":"SS Zoroglu","year":"2004","unstructured":"Zoroglu SS, et al. Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur Arch Psychiatry Clin Neurosci. 2004;254(3):143\u20137.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"8","key":"298_CR18","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.archoralbio.2012.03.006","volume":"57","author":"K Rai","year":"2012","unstructured":"Rai K, Hegde AM, Jose N. Salivary antioxidants and oral health in children with autism. Arch Oral Biol. 2012;57(8):1116\u201320.","journal-title":"Arch Oral Biol"},{"issue":"1","key":"298_CR19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12011-010-8840-9","volume":"143","author":"NA Meguid","year":"2011","unstructured":"Meguid NA, et al. Evaluation of oxidative stress in autism: defective antioxidant enzymes and increased lipid peroxidation. Biol Trace Elem Res. 2011;143(1):58\u201365.","journal-title":"Biol Trace Elem Res"},{"issue":"4","key":"298_CR20","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s11064-011-0667-z","volume":"37","author":"A Ghanizadeh","year":"2012","unstructured":"Ghanizadeh A. Malondialdehyde, Bcl-2, superoxide dismutase and glutathione peroxidase may mediate the association of sonic hedgehog protein and oxidative stress in autism. Neurochem Res. 2012;37(4):899\u2013901.","journal-title":"Neurochem Res"},{"issue":"1438","key":"298_CR21","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1098\/rstb.2003.1358","volume":"358","author":"SM Allan","year":"2003","unstructured":"Allan SM, Rothwell NJ. Inflammation in central nervous system injury. Philos Trans R Soc Lond B Biol Sci. 2003;358(1438):1669\u201377.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1\u20132","key":"298_CR22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.molbrainres.2005.03.010","volume":"137","author":"AS Moolwaney","year":"2005","unstructured":"Moolwaney AS, Igwe OJ. Regulation of the cyclooxygenase-2 system by interleukin-1beta through mitogen-activated protein kinase signaling pathways: a comparative study of human neuroglioma and neuroblastoma cells. Brain Res Mol Brain Res. 2005;137(1\u20132):202\u201312.","journal-title":"Brain Res Mol Brain Res"},{"issue":"3","key":"298_CR23","first-page":"391","volume":"39","author":"WY Ong","year":"1999","unstructured":"Ong WY, et al. Distribution of cytoplasmic phospholipase A2 in the normal rat brain. J Hirnforsch. 1999;39(3):391\u2013400.","journal-title":"J Hirnforsch"},{"issue":"2","key":"298_CR24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0169-328X(02)00353-4","volume":"104","author":"S Kyrkanides","year":"2002","unstructured":"Kyrkanides S, et al. Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury. Brain Res Mol Brain Res. 2002;104(2):159\u201369.","journal-title":"Brain Res Mol Brain Res"},{"issue":"9","key":"298_CR25","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1089\/ars.2010.3547","volume":"15","author":"V Chiurchi\u00f9","year":"2011","unstructured":"Chiurchi\u00f9 V, Maccarrone M. Chronic inflammatory disorders and their redox control: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2011;15(9):2605\u201341.","journal-title":"Antioxid Redox Signal"},{"issue":"Suppl 1","key":"298_CR26","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1080\/13547500500216546","volume":"10","author":"GL Milne","year":"2005","unstructured":"Milne GL, Musiek ES, Morrow JD. F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers. 2005;10 Suppl 1:S10\u201323.","journal-title":"Biomarkers"},{"issue":"8","key":"298_CR27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00011-012-0468-0","volume":"61","author":"S Sciascia","year":"2012","unstructured":"Sciascia S, et al. 8-isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study. Inflamm Res. 2012;61(8):809\u201316.","journal-title":"Inflamm Res"},{"key":"298_CR28","doi-asserted-by":"crossref","first-page":"572491","DOI":"10.1155\/2014\/572491","volume":"2014","author":"E Miller","year":"2014","unstructured":"Miller E, et al. Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseases. Oxidative Med Cell Longev. 2014;2014:572491.","journal-title":"Oxidative Med Cell Longev"},{"issue":"6","key":"298_CR29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2222.2006.02498.x","volume":"36","author":"M Peters-Golden","year":"2006","unstructured":"Peters-Golden M, Gleason MM, Togias A. Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis. Clin Exp Allergy. 2006;36(6):689\u2013703.","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"298_CR30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.plefa.2009.01.007","volume":"80","author":"MM Wiest","year":"2009","unstructured":"Wiest MM, et al. Plasma fatty acid profiles in autism: a case\u2013control study. Prostaglandins Leukot Essent Fatty Acids. 2009;80(4):221\u20137.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"4","key":"298_CR31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.plefa.2006.02.001","volume":"74","author":"B Bu","year":"2006","unstructured":"Bu B, et al. Fatty acid compositions of red blood cell phospholipids in children with autism. Prostaglandins Leukot Essent Fatty Acids. 2006;74(4):215\u201321.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"2","key":"298_CR32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000323189","volume":"18","author":"J Tamiji","year":"2010","unstructured":"Tamiji J, Crawford DA. The neurobiology of lipid metabolism in autism spectrum disorders. Neurosignals. 2010;18(2):98\u2013112.","journal-title":"Neurosignals"},{"key":"298_CR33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1476-511X-10-63","volume":"10","author":"AK El-Ansary","year":"2011","unstructured":"El-Ansary AK, Bacha AG, Al-Ayahdi LY. Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia. Lipids Health Dis. 2011;10:63.","journal-title":"Lipids Health Dis"},{"issue":"6","key":"298_CR34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/BF02178189","volume":"25","author":"M Hauck","year":"1995","unstructured":"Hauck M, et al. Social initiations by autistic children to adults and other children. J Autism Dev Disord. 1995;25(6):579\u201395.","journal-title":"J Autism Dev Disord"},{"issue":"6","key":"298_CR35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1023\/A:1005647629002","volume":"30","author":"WL Stone","year":"2000","unstructured":"Stone WL, Coonrod EE, Ousley OY. Brief report: screening tool for autism in two-year-olds (STAT): development and preliminary data. J Autism Dev Disord. 2000;30(6):607\u201312.","journal-title":"J Autism Dev Disord"},{"issue":"2","key":"298_CR36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1022927124025","volume":"33","author":"CT Jackson","year":"2003","unstructured":"Jackson CT, et al. Responses and sustained interactions in children with mental retardation and autism. J Autism Dev Disord. 2003;33(2):115\u201321.","journal-title":"J Autism Dev Disord"},{"issue":"3","key":"298_CR37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/07419325070280030401","volume":"28","author":"S Bellini","year":"2007","unstructured":"Bellini S, et al. A meta-analysis of school-based social skills interventions for children with autism spectrum disorders. Remedial Spec Educ. 2007;28(3):153\u201362.","journal-title":"Remedial Spec Educ"},{"issue":"5","key":"298_CR38","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/j.1467-8624.2010.01481.x","volume":"81","author":"E Pellicano","year":"2010","unstructured":"Pellicano E. The development of core cognitive skills in autism: a 3-year prospective study. Child Dev. 2010;81(5):1400\u201316.","journal-title":"Child Dev"},{"issue":"1535","key":"298_CR39","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1098\/rstb.2009.0191","volume":"364","author":"S Baron-Cohen","year":"2009","unstructured":"Baron-Cohen S, Golan O, Ashwin E. Can emotion recognition be taught to children with autism spectrum conditions? Philos Trans R Soc Lond B Biol Sci. 2009;364(1535):3567\u201374.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"5","key":"298_CR40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ridd.2007.08.003","volume":"29","author":"E Ben Itzchak","year":"2008","unstructured":"Ben Itzchak E, et al. Cognitive, behavior and intervention outcome in young children with autism. Res Dev Disabil. 2008;29(5):447\u201358.","journal-title":"Res Dev Disabil"},{"issue":"2","key":"298_CR41","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5014\/ajot.61.2.190","volume":"61","author":"SD Tomchek","year":"2007","unstructured":"Tomchek SD, Dunn W. Sensory processing in children with and without autism: A comparative study using the short sensory profile. Am J Occup Ther. 2007;61(2):190\u2013200.","journal-title":"Am J Occup Ther"},{"issue":"2","key":"298_CR42","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ridd.2010.10.021","volume":"32","author":"L Klintwall","year":"2011","unstructured":"Klintwall L, et al. Sensory abnormalities in autism. A brief report. Res Dev Disabil. 2011;32(2):795\u2013800.","journal-title":"Res Dev Disabil"},{"issue":"5","key":"298_CR43","doi-asserted-by":"crossref","first-page":"586","DOI":"10.5014\/ajot.2012.004168","volume":"66","author":"S O'Donnell","year":"2012","unstructured":"O'Donnell S, et al. Sensory processing, problem behavior, adaptive behavior, and cognition in preschool children with autism spectrum disorders. Am J Occup Ther. 2012;66(5):586\u201394.","journal-title":"Am J Occup Ther"},{"key":"298_CR44","unstructured":"Mick K. Diagnosing Autism: Comparison of the Childhood Autism Rating Scale (CARS) and the Autism Diagnostic Observation Schedule (ADOS). PhD Dissertation. 2005."},{"issue":"4","key":"298_CR45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1025014929212","volume":"33","author":"JN Constantino","year":"2003","unstructured":"Constantino JN, et al. Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised. J Autism Dev Disord. 2003;33(4):427\u201333.","journal-title":"J Autism Dev Disord"},{"key":"298_CR46","doi-asserted-by":"crossref","unstructured":"Dunn, W. The short sensory profile. The Psychological Corporation;1999.","DOI":"10.1037\/t15155-000"},{"issue":"5","key":"298_CR47","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1471-4159.2006.03797.x","volume":"97","author":"ES Musiek","year":"2006","unstructured":"Musiek ES, et al. Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration. J Neurochem. 2006;97(5):1301\u201313.","journal-title":"J Neurochem"},{"issue":"5","key":"298_CR48","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.52.5.1104","volume":"52","author":"TJ Montine","year":"1999","unstructured":"Montine TJ, et al. Cerebrospinal fluid F-2-isoprostanes are elevated in Huntington's disease. Neurology. 1999;52(5):1104\u20135.","journal-title":"Neurology"},{"key":"298_CR49","unstructured":"Richardson DM, Best PJM, Lerman A. Plasma F2-isoprostanes are a marker of oxidative stress in humans. FASEB J. 2000;14(4):A121\u20131."},{"key":"298_CR50","unstructured":"Best PJM, et al. Plasma F-2-isoprostanes are a marker of oxidative stress which are elevated in patients with unstable coronary syndromes. J Am Coll Cardiol. 2000;35(2):404a\u2013a."},{"issue":"8","key":"298_CR51","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/MCA.0b013e3282f0efa5","volume":"18","author":"I Basarici","year":"2007","unstructured":"Basarici I, et al. Associations of isoprostanes-related oxidative stress with surrogate subclinical indices and angiographic measures of atherosclerosis. Coron Artery Dis. 2007;18(8):615\u201320.","journal-title":"Coron Artery Dis"},{"issue":"4","key":"298_CR52","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1212\/WNL.61.4.436","volume":"61","author":"MC Irizarry","year":"2003","unstructured":"Irizarry MC, Hyman BT. Brain isoprostanes: a marker of lipid peroxidation and oxidative stress in AD. Neurology. 2003;61(4):436\u20137.","journal-title":"Neurology"},{"issue":"11","key":"298_CR53","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.3390\/ijms11114631","volume":"11","author":"M Janicka","year":"2010","unstructured":"Janicka M, et al. Isoprostanes-Biomarkers of Lipid Peroxidation: Their Utility in Evaluating Oxidative Stress and Analysis. Int J Mol Sci. 2010;11(11):4631\u201359.","journal-title":"Int J Mol Sci"},{"issue":"1\u20132","key":"298_CR54","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jneuroim.2009.12.003","volume":"219","author":"GA Mostafa","year":"2010","unstructured":"Mostafa GA, et al. Oxidative stress in Egyptian children with autism: relation to autoimmunity. J Neuroimmunol. 2010;219(1\u20132):114\u20138.","journal-title":"J Neuroimmunol"},{"key":"298_CR55","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1476-511X-11-160","volume":"11","author":"A El-Ansary","year":"2012","unstructured":"El-Ansary A, Al-Ayadhi L. Lipid mediators in plasma of autism spectrum disorders. Lipids Health Dis. 2012;11:160.","journal-title":"Lipids Health Dis"},{"issue":"3","key":"298_CR56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/039463200301600302","volume":"16","author":"A Vojdani","year":"2003","unstructured":"Vojdani A, et al. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int J Immunopathol Pharmacol. 2003;16(3):189\u201399.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"8","key":"298_CR57","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archneur.63.8.1161","volume":"63","author":"Y Yao","year":"2006","unstructured":"Yao Y, et al. Altered vascular phenotype in autism: correlation with oxidative stress. Arch Neurol. 2006;63(8):1161\u20134.","journal-title":"Arch Neurol"},{"issue":"1","key":"298_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00247-001-0570-x","volume":"32","author":"N Boddaert","year":"2002","unstructured":"Boddaert N, Zilbovicius M. Functional neuroimaging and childhood autism. Pediatr Radiol. 2002;32(1):1\u20137.","journal-title":"Pediatr Radiol"},{"issue":"1","key":"298_CR59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000063570","volume":"46","author":"J Wilcox","year":"2002","unstructured":"Wilcox J, et al. Brain perfusion in autism varies with age. Neuropsychobiology. 2002;46(1):13\u20136.","journal-title":"Neuropsychobiology"},{"issue":"5","key":"298_CR60","doi-asserted-by":"crossref","first-page":"C1399","DOI":"10.1152\/ajpcell.00386.2005","volume":"290","author":"H Parfenova","year":"2006","unstructured":"Parfenova H, et al. Glutamate induces oxidative stress and apoptosis in cerebral vascular endothelial cells: contributions of HO-1 and HO-2 to cytoprotection. Am J Physiol Cell Physiol. 2006;290(5):C1399\u2013410.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"298_CR61","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1089\/neu.2011.1754","volume":"29","author":"F Clausen","year":"2012","unstructured":"Clausen F, et al. Interstitial F(2)-isoprostane 8-iso-PGF(2alpha) as a biomarker of oxidative stress after severe human traumatic brain injury. J Neurotrauma. 2012;29(5):766\u201375.","journal-title":"J Neurotrauma"},{"issue":"2","key":"298_CR62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/089771504322778596","volume":"21","author":"AK Wagner","year":"2004","unstructured":"Wagner AK, Bayir H, Ren D, Puccio A, Zafonte RD, Kochanek PM. Relationships between Cerebrospinal Fluid Markers of Excitotoxicity, Ischemia, and Oxidative Damage after Severe TBI: The Impact of Gender, Age, and Hypothermia. J Neurotrauma. 2004;21(2):125\u201336.","journal-title":"J Neurotrauma"},{"issue":"4","key":"298_CR63","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1081\/JAS-120018709","volume":"40","author":"M Suzuki","year":"2003","unstructured":"Suzuki M, et al. Inhibition of human eosinophil activation by a cysteinyl leukotriene receptor antagonist (Praniukast; ONO-1078). J Asthma. 2003;40(4):395\u2013404.","journal-title":"J Asthma"},{"issue":"2","key":"298_CR64","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0022-3565(24)37477-4","volume":"285","author":"MA McAlexander","year":"1998","unstructured":"McAlexander MA, Myers AC, Undem BJ. Inhibition of 5-lipoxygenase diminishes neurally evoked tachykinergic contraction of guinea pig isolated airway. J Pharmacol Exp Ther. 1998;285(2):602\u20137.","journal-title":"J Pharmacol Exp Ther"},{"key":"298_CR65","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1113\/jphysiol.1991.sp018561","volume":"436","author":"JL Ellis","year":"1991","unstructured":"Ellis JL, Undem BJ. Role of Peptidoleukotrienes in Capsaicin-Sensitive Sensory Fiber-Mediated Responses in Guinea-Pig Airways. J Physiol. 1991;436:469\u201384.","journal-title":"J Physiol"},{"issue":"2","key":"298_CR66","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1152\/jappl.1998.84.2.537","volume":"84","author":"AM Sanico","year":"1998","unstructured":"Sanico AM, et al. Plasma extravasation through neuronal stimulation in human nasal mucosa in the setting of allergic rhinitis. J Appl Physiol. 1998;84(2):537\u201343.","journal-title":"J Appl Physiol"},{"issue":"12","key":"298_CR67","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1745-7254.2006.00438.x","volume":"27","author":"Q Ding","year":"2006","unstructured":"Ding Q, et al. Cysteinyl leukotriene receptor 1 is involved in N-methyl-D-aspartate-mediated neuronal injury in mice. Acta pharmacologica Sinica. 2006;27(12):1526\u201336.","journal-title":"Acta pharmacologica Sinica"},{"issue":"6","key":"298_CR68","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/j.1460-9568.2004.03613.x","volume":"20","author":"R Ciccarelli","year":"2004","unstructured":"Ciccarelli R, et al. Cysteinyl-leukotrienes are released from astrocytes and increase astrocyte proliferation and glial fibrillary acidic protein via cys-LT1 receptors and mitogen-activated protein kinase pathway. Eur J NeuroSci. 2004;20(6):1514\u201324.","journal-title":"Eur J NeuroSci"},{"issue":"3","key":"298_CR69","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.neuroscience.2006.02.051","volume":"140","author":"SH Fang","year":"2006","unstructured":"Fang SH, et al. Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats. Neuroscience. 2006;140(3):969\u201379.","journal-title":"Neuroscience"},{"key":"298_CR70","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.neuroscience.2014.07.058","volume":"277","author":"QF Lenz","year":"2014","unstructured":"Lenz QF, et al. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood\u2013brain barrier dysfunction. Neuroscience. 2014;277:859\u201371.","journal-title":"Neuroscience"},{"key":"298_CR71","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.nut.2013.01.012","volume":"10","author":"UN Das","year":"2013","unstructured":"Das UN. Autism as a disorder of deficiency of brain-derived neurotrophic factor and altered metabolism of polyunsaturated fatty acids. Nutrition. 2013;10:1175\u201385.","journal-title":"Nutrition"},{"issue":"7\u20138","key":"298_CR72","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.nut.2012.11.013","volume":"29","author":"UN Das","year":"2013","unstructured":"Das UN. Nutritional factors in the pathobiology of autism. Nutrition. 2013;29(7\u20138):1066\u20139.","journal-title":"Nutrition"},{"issue":"12","key":"298_CR73","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s10803-010-1005-z","volume":"40","author":"JL Taylor","year":"2010","unstructured":"Taylor JL, Seltzer MM. Changes in the autism behavioral phenotype during the transition to adulthood. J Autism Dev Disord. 2010;40(12):1431\u201346.","journal-title":"J Autism Dev Disord"},{"key":"298_CR74","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s10803-006-0307-7","volume":"37","author":"P Shattuck","year":"2007","unstructured":"Shattuck P. Autism Improves in Adulthood. J Autism Dev Disord. 2007;37:1735\u201347.","journal-title":"J Autism Dev Disord"},{"issue":"9","key":"298_CR75","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s10803-008-0548-8","volume":"38","author":"S Fletcher-Watson","year":"2008","unstructured":"Fletcher-Watson S, et al. Brief report: young adults with autism spectrum disorder show normal attention to eye-gaze information-evidence from a new change blindness paradigm. J Autism Dev Disord. 2008;38(9):1785\u201390.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"298_CR76","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10803-008-0599-x","volume":"39","author":"AJ Esbensen","year":"2009","unstructured":"Esbensen AJ, et al. Age-related differences in restricted repetitive behaviors in autism spectrum disorders. J Autism Dev Disord. 2009;39(1):57\u201366.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"298_CR77","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchromb.2005.04.023","volume":"827","author":"E Mariani","year":"2005","unstructured":"Mariani E, et al. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;827(1):65\u201375.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"3","key":"298_CR78","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0008-6363(00)00097-3","volume":"47","author":"B Halliwell","year":"2000","unstructured":"Halliwell B. Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward? Cardiovasc Res. 2000;47(3):410\u20138.","journal-title":"Cardiovasc Res"},{"key":"298_CR79","first-page":"174","volume":"10","author":"T Fujiwara","year":"2016","unstructured":"Fujiwara T, Morisaki N, Honda Y, Sampei M, Tani Y. Chemicals, Nutrition, and Autism Spectrum Disorder: A Mini-Review. Front Neurosci. 2016;10:174.","journal-title":"Front Neurosci"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-016-0298-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:39:01Z","timestamp":1749062341000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-016-0298-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,17]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["298"],"URL":"https:\/\/doi.org\/10.1186\/s12944-016-0298-0","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,17]]},"article-number":"130"}}